Binding of thiazolidinediones to the endoplasmic reticulum protein nutrient-deprivation autophagy factor-1

Bioorganic & Medicinal Chemistry Letters
2019.0

Abstract

Nutrient-deprivation autophagy factor-1 (NAF-1, miner1; gene cisd2) is part of the [2Fe-2S]-containing protein family which includes mitoNEET (gene cisd1) and MiNT (miner2; gene cisd3). These proteins are redox active and are thought to play an important role in cellular energy homeostasis with NAF-1 playing a critical role in calcium regulation and aging. To date, no studies have investigated potential ligand interaction with NAF-1. Here we show that the thiazolidinediones pioglitazone and rosiglitazone along with the mitoNEET ligand, NL-1, bind to NAF-1 with low micromolar affinities. Further, we show that overexpression of NAF-1 in hepatocellular carcinoma (HepG2) cells reduces inhibition of mitochondrial respiration by pioglitazone. Our findings support the need for further efforts of the rational design of selective NAF-1 ligands.

Knowledge Graph

Similar Paper

Binding of thiazolidinediones to the endoplasmic reticulum protein nutrient-deprivation autophagy factor-1
Bioorganic & Medicinal Chemistry Letters 2019.0
Identification of small molecules that bind to the mitochondrial protein mitoNEET
Bioorganic & Medicinal Chemistry Letters 2016.0
Structure-based design of a thiazolidinedione which targets the mitochondrial protein mitoNEET
Bioorganic & Medicinal Chemistry Letters 2010.0
Homology modeling and explicit membrane molecular dynamics simulation to delineate the mode of binding of thiazolidinediones into FFAR1 and the mechanism of receptor activation
Bioorganic & Medicinal Chemistry Letters 2014.0
PPARγ-sparing thiazolidinediones as insulin sensitizers. Design, synthesis and selection of compounds for clinical development
Bioorganic & Medicinal Chemistry 2018.0
Chemical Proteomics-Based Analysis of Off-Target Binding Profiles for Rosiglitazone and Pioglitazone: Clues for Assessing Potential for Cardiotoxicity
Journal of Medicinal Chemistry 2012.0
Synthesis and Biological Activity of Metabolites of the Antidiabetic, Antihyperglycemic Agent Pioglitazone
Journal of Medicinal Chemistry 1996.0
Peroxisome Proliferator-Activated Receptor γ (PPARγ) and Ligand Choreography: Newcomers Take the Stage
Journal of Medicinal Chemistry 2015.0
Design, synthesis, and biological evaluation of novel thiazolidinediones as PPARγ/FFAR1 dual agonists
European Journal of Medicinal Chemistry 2016.0
Anti-diabetic activity of fused PPARγ-SIRT1 ligands with limited body-weight gain by mimicking calorie restriction and decreasing SGK1 expression
European Journal of Medicinal Chemistry 2017.0